BMS Admits to International Bribery Probe by SEC, Justice Department
Bristol-Myers Squibb (BMS) admitted the SEC has launched an investigation under the Foreign Corrupt Practices Act (FCPA) into its sales and marketing practices in various countries.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.